|
Intraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis
RECRUITINGN/ASponsored by Tanta University
Actively Recruiting
PhaseN/A
SponsorTanta University
Started2026-06-24
Est. completion2026-12-01
Eligibility
Age50 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07666347
Summary
This study aims to compare the efficacy of intra-articular injection of Botulinum toxin and hyaluronic acid on pain in knee osteoarthritis.
Eligibility
Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria: * Age ≥ 50 years. * Both genders. * Chronic knee osteoarthritis (KOA) according to American College of Rheumatology criteria for the diagnosis of knee osteoarthritis. * Third or fourth grade Kellgren and Lawrence system for classification of osteoarthritis based on radiological data, it is a common method of classifying the severity of osteoarthritis (OA) using five grades according to the following sites and projections. Exclusion Criteria: * History of intra-articular injection within the last 6 months, * History of surgery on the knee joint or major trauma to the lower limb causing fracture. * Body mass index (BMI) more than 40 kg/m2. * Medical conditions affecting the joint or lower extremity function such as severe osteoporosis, rheumatoid arthritis, collagen vascular diseases, and gout. * Diabetic patient. * Any contraindication to intra-articular injections for instance immunodeficiency, coagulation defect or anticoagulation therapy taking or skin infection at the site of injection. * Hypersensitivity to Botulinum toxin or hyaluronic acid.
Conditions5
ArthritisBOTOXHyaluronic AcidIntraarticular InjectionKnee Osteoarthritis
Interventions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorTanta University
Started2026-06-24
Est. completion2026-12-01
Eligibility
Age50 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07666347